At a glance
ClinicalIndex Comparison RecordN/ACompleted· 11 enrolled
Drug / intervention
Blue light phototherapydevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Development & Preliminary Clinical Validation Blue Light Phototherapy Systems for T-Cell
In Brief
A clinical study evaluating Blue light phototherapy for Grover's Disease and Psoriasis Vulgaris. Completed, enrolled 11 participants across 1 site.
Detailed Summary
This study will use Blue-light Photo-therapy to treat patients with psoriasis vulgaris and Grover's Disease.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsGrover's Disease, Psoriasis Vulgaris
CountriesUnited States
CollaboratorsT-Cellerate LLC
Timeline
N/ACompletedFinished
202120222023202420252026
First PostedApr 2020
Enrollment StartSep 2020
Primary CompletionDec 2021
Study CompletionSep 2022
TodayJul 2026
First PostedApr 13, 2020
Enrollment StartSep 1, 2020
Primary CompletionDec 20, 2021
Study CompletionSep 22, 2022
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 6.2 years ago
Interventions
Blue light phototherapydevice
Phototherapy- Wavelength: 417±15 nm